The offering provides cash runway through the HLP003 Phase 3 APPROACH data readout in Q4 2026, which is the next major catalyst. Monitor for data release and any subsequent capital needs. The dilution is already priced in, but further weakness may occur if the market anticipates additional offerings.
Price Chart
Executive Summary
Cybin Inc. (HELP) filed a material change report confirming the pricing and closing of a $50M underwritten offering of 10.3M common shares at $4.85 per share. The offering closed on June 25, 2026, with net proceeds earmarked for advancing HLP003 (Phase 3 APPROACH data expected Q4 2026), HLP004, HLP005 programs, and working capital. The ~12% dilution is a material negative, though the cash runway funds key catalysts.
Key Facts
- Underwritten offering of 10,309,280 common shares at US$4.85 per share for aggregate gross proceeds of US$50 million.
- Offering closed on June 25, 2026.
- Underwriters paid a cash commission of US$3 million.
- Net proceeds to fund HLP003 Phase 3 APPROACH data (expected Q4 2026), HLP004, HLP005, and working capital.
- Joint bookrunning managers: Cantor Fitzgerald & Co. and Barclays Capital Inc.
Financial Impact
Dilution of approximately 12% of pre-offering market capitalization ($404M); $3M in underwriting fees.
Risk Factors
- Clinical trial failure of HLP003 or other pipeline programs.
- Need for further dilutive financing before reaching profitability.
- Competition from other psychedelic/mental health therapies.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (HELP) — Batch item 1 | 0001062993-26-003691 |
| Document: form6k.htm | 0001062993-26-003691 |
| Document: 0001062993-26-003691-index-headers.html | 0001062993-26-003691 |
| Document: 0001062993-26-003691-index.html | 0001062993-26-003691 |
| Document: 0001062993-26-003691.txt | 0001062993-26-003691 |
| 6-K Filing (HELP) — Batch item 6 | 0001062993-26-003691 |
| Document: form6k.htm | 0001062993-26-003691 |
| Document: 0001062993-26-003691-index-headers.html | 0001062993-26-003691 |
| Document: 0001062993-26-003691-index.html | 0001062993-26-003691 |
| Document: 0001062993-26-003691.txt | 0001062993-26-003691 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 3 | $10.86 | awaiting T+20 | — | $10.73 (−1.15%) |
Oct 23, 2026 2d ago | 3 | $10.50 | awaiting T+20 | — | $10.73 (+2.19%) |
Oct 23, 2026 2d ago | 3 | $10.50 | awaiting T+20 | — | $10.73 (+2.19%) |
Oct 23, 2026 2d ago | 3 | $10.50 | awaiting T+20 | — | $10.73 (+2.19%) |
Oct 23, 2026 2d ago | 3 | $10.50 | awaiting T+20 | — | $10.73 (+2.19%) |
Oct 21, 2026 4d ago | 6-K | $10.50 | awaiting T+20 | — | $10.73 (+2.19%) |
Oct 15, 2026 11d ago | 6-K | $11.05 | awaiting T+20 | — | $10.73 (−2.90%) |
Oct 15, 2026 11d ago | Press Release | $11.05 | awaiting T+20 | — | $10.73 (−2.90%) |
Oct 8, 2026 18d ago | 6-K | $10.72 | awaiting T+20 | — | $10.73 (+0.09%) |
Oct 5, 2026 21d ago | 6-K | $11.42 | awaiting T+20 | — | $10.73 (−6.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers